GLP-1 and GIP: The Incretin Synergy Tirzepatide is the first medication to act as a dual agonist of: Glucagon-like peptide-1 (GLP-1) receptor Glucose-dependent insulinotropic polypeptide (GIP) receptor These two hormones are part of the incretin system, a group of gut-derived peptides released in response to food intake
The rule that the bigger pack is always the better deal quietly stops holding
In one study, people with obesity and PMOS lost more weight when they took metformin and liraglutide together, compared with either drug by itself
If your glutathione levels are low, the liver can become overwhelmed, leading to a buildup of oxidative stress
And shipping came in 2 days Absolutely love this product and your customer service
Sarah calls this the "valley of death" : your endogenous GLP-1 is nearly zero, hunger skyrockets, and people rapidly regain weight